Pilot Test of a Novel Behavioral Intervention on BP Control in HTN Patients
Pilot Test of a Novel Behavioral Intervention on BP Control in HTN Patients
批准号:
7731175
负责人:
WILLIAM GERIN
金额:
$75.44万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-07-31
关键词:
AffectAreaBehaviorBehavior TherapyBehavioralBeliefBlood PressureChronic DiseaseClassificationClinicalComplexComputersDecision MakingDiseaseEconomic BurdenEducational InterventionEducational MaterialsEffectivenessEnsureFeedbackGoalsGrantHealth PersonnelHome Blood Pressure MonitoringHome environmentHypertensionInterventionJointsKnowledgeLeadLife StyleLiteratureManuscriptsMediatingMethodsModelingMonitorMorbidity - disease rateOutcomeParentsPathway interactionsPatient EducationPatientsPharmaceutical PreparationsPhysiciansPrintingProcessProgrammed InstructionRandomizedRandomized Controlled TrialsRecruitment ActivityResearch PersonnelRiskSelf EfficacySelf ManagementSelf-Instruction ProgramTechniquesTestingTimeTreatment ProtocolsUnited StatesWorkbaseblood pressure regulationcostcost effectivenessdata acquisitiondesignfollow-uphypertension controlhypertension treatmentinnovationintervention effectmedication complianceneglectnovelpreventprogramspublic health relevanceresponsesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The mechanisms of action of vitamin E, a potent lipid soluble antioxidant that is necessary for
reproduction, are unknown [1]. A dichotomy exists between vitamin E’s antioxidant and biologic activities,
in that plants synthesize eight different molecules with vitamin E antioxidant activity, yet only one of
these, -tocopherol, is a nutrient required by animals. We believe that the lack of success in determining
the molecular function of -tocopherol results from two major obstacles. First, -tocopherol requires
special transport mechanisms for delivery to tissues and is involved in complex interactions between
various oxidizing and antioxidant systems; these factors make outcomes from cell culture studies largely
misleading. Secondly, it is difficult using experimental animals to obtain tissues (especially embryos) that
are sufficiently -tocopherol-depleted to be useful to identify -tocopherol-sensitive functions. To obviate
these problems, we propose to use vitamin E-depleted zebrafish (Danio rerio) as a model system.
Zebrafish are vertebrate animals with genes generally homologous to those of humans, large numbers of
animals can be raised, diets can easily be manipulated, targeted genes can be readily modified, and
embryonic stages can be studied over the course of development. Critically, the -tocopherol transfer
protein (-TTP) is expressed in human yolk sac [2], is abundantly expressed by the 48 hour postfertilization
(hpf) zebrafish embryo and its expression increases with oxidative stress [3]. Therefore, -
TTP likely mediates -tocopherol transfer to the embryo from the yolk sac.
To study -tocopherol-deficient (E-) zebrafish, we have developed a defined, -tocopherol-deficient diet
and demonstrate in preliminary studies that E-zebrafish are fertile and capable of producing viable, Eembryos.
By 48 hpf, many E- embryos exhibit severe developmental malformations. Defects include
craniofacial and cardiovascular abnormalities, thereby linking -tocopherol requirements to neurological
and cardiovascular development.
Based on our literature review, we hypothesize that -tocopherol provides antioxidant protection for
specific, key lipid mediators necessary for embryonic development, including cell loss via programmed
cell death. Specifically, glutathione peroxidase 4 (GPx4), a detoxifier of phospholipid hydroperoxides,
senses and translates oxidative stress into cell death that is mediated by both 12/15-lipoxygenase (12/15
LOX) and apoptosis-inducing factor (AIF) [4]. Importantly, -tocopherol, but not water-soluble
antioxidants, efficiently prevented cell death. These findings support the hypothesis that -tocopherol is
necessary during embryogenesis to modulate lipid mediators involved in specific developmental steps,
especially in the nervous system. To test this hypothesis, we propose the following aims:
Aim 1. Define the role of the -tocopherol transfer protein (-TTP) during embryonic development
Hypothesis: -TTP is present in the yolk sac of the embryo, and is expressed in increasing amounts
during embryonic development, to facilitate -tocopherol transfer to key sites. -Tocopherol is necessary
for the earliest cells in embryonic development to allow appropriate lipid-mediator regulation.
Aim 2. Define the roles of oxidant and antioxidant apoptosis regulators during embryonic
development
Hypothesis: -tocopherol is necessary to prevent abnormal lipid peroxidation of key mediators. 12/15-
LOX increases lipid peroxidation thereby signaling AIF translocation and cell death. Opposing 12/15-LOX
is GPX4, which uses glutathione (as a co-factor) and detoxifies phospholipid hydroperoxides. Thus,
GPX4 suppresses lipid peroxidation. -Tocopherol not only stops the lipid peroxidation chain reaction, it
is absolutely required for reproduction. Therefore, -tocopherol will prevent, and its absence will
potentiate, developmental abnormalities if either GSH synthesis or GPX4 expression is abrogated. If
12/15-LOX or AIF expression is knocked down, -tocopherol will have a lesser effect.
Aim 3. Define the role of -tocopherol in the developing nervous system
Hypothesis: The nervous system is especially sensitive to -tocopherol deficiency; therefore, the lack of
-tocopherol in the developing embryo will result in specific nervous system malformation and
dysfunction.
The zebrafish model is ideal for our studies because it, like humans, has a preference for -tocopherol,
expresses the ttp gene and requires vitamin C, an important determinant in -tocopherol antioxidant
function in humans [5]. Moreover, the -tocopherol deficient zebrafish embryo displays characteristic
abnormalities suggesting dysfunctional neurological and cardiovascular development. Our long-term goal
is to define molecular targets altered by -tocopherol-deficiency because this mechanistic data can then
be tested in other model systems, ultimately translating these results to our basic understanding of why
humans require -tocopherol, not just for reproduction, but also to maintain a healthy nervous system.
The zebrafish allows us to distinguish the effect of -tocopherol deficiency in the embryo itself, separate
from maternal -tocopherol deficiency during gestation. With that in mind, our approach is to let our
biological system respond to the insult (-tocopherol-deficiency), and then pursue the underlying
mechanism by exploiting the advantages of the zebrafish model. Using this approach, our zebrafish
studies will allow us to document specific -tocopherol molecular functions, key antioxidant/oxidant
signaling mechanisms, as well as determining at what stages -tocopherol is required
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot Test of a Novel Behavioral Intervention on BP Control in HTN Patients
-
批准号:7933829
-
项目类别:
-
资助金额:$75.22万
-
财政年份:2009
-
负责人:WILLIAM GERIN
-
依托单位:
A Web-Based Intervention, "E-HTN", Improves Blood Pressure Control
-
批准号:7110665
-
项目类别:
-
资助金额:$11.48万
-
财政年份:2006
-
负责人:WILLIAM GERIN
-
依托单位:
TRIALS OF THE LIFESKILLS WORKSHOP IN HYPERTENSIVES
-
批准号:7205980
-
项目类别:
-
资助金额:$2.29万
-
财政年份:2005
-
负责人:WILLIAM GERIN
-
依托单位:
Core--Mechanisms and Measures
-
批准号:6953905
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2004
-
负责人:WILLIAM GERIN
-
依托单位:
A STEPPED NTERVENTION FOR MEDS ADHERENCE & BP CONTROL
-
批准号:6899565
-
项目类别:
-
资助金额:$3.87万
-
财政年份:2001
-
负责人:WILLIAM GERIN
-
依托单位:
A STEPPED NTERVENTION FOR MEDS ADHERENCE & BP CONTROL
-
批准号:6931128
-
项目类别:
-
资助金额:$73.85万
-
财政年份:2001
-
负责人:WILLIAM GERIN
-
依托单位:
A STEPPED NTERVENTION FOR MEDS ADHERENCE & BP CONTROL
-
批准号:6798951
-
项目类别:
-
资助金额:$3.85万
-
财政年份:2001
-
负责人:WILLIAM GERIN
-
依托单位:
A STEPPED NTERVENTION FOR MEDS ADHERENCE & BP CONTROL
-
批准号:6527977
-
项目类别:
-
资助金额:$54.3万
-
财政年份:2001
-
负责人:WILLIAM GERIN
-
依托单位:
A STEPPED INTERVENTION FOR MEDS ADHERENCE & BP CONTROL
-
批准号:6323525
-
项目类别:
-
资助金额:$67.38万
-
财政年份:2001
-
负责人:WILLIAM GERIN
-
依托单位:
A STEPPED NTERVENTION FOR MEDS ADHERENCE & BP CONTROL
-
批准号:6800338
-
项目类别:
-
资助金额:$68.95万
-
财政年份:2001
-
负责人:WILLIAM GERIN
-
依托单位:
A STEPPED NTERVENTION FOR MEDS ADHERENCE & BP CONTROL
-
批准号:6658051
-
项目类别:
-
资助金额:$56.29万
-
财政年份:2001
-
负责人:WILLIAM GERIN
-
依托单位:
EMOTIONAL DISCLOSURE WRITING EFFECTS ON BLOOD PRESSURE
-
批准号:6527997
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2000
-
负责人:WILLIAM GERIN
-
依托单位:
EMOTIONAL DISCLOSURE WRITING EFFECTS ON BLOOD PRESSURE
-
批准号:6503143
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2000
-
负责人:WILLIAM GERIN
-
依托单位:
EMOTIONAL DISCLOSURE WRITING EFFECTS ON BLOOD PRESSURE
-
批准号:6391010
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2000
-
负责人:WILLIAM GERIN
-
依托单位:
EMOTIONAL DISCLOSURE WRITING EFFECTS ON BLOOD PRESSURE
-
批准号:6347094
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2000
-
负责人:WILLIAM GERIN
-
依托单位:
PATIENT FRIENDLY TELEPHONE LINKED BLOOD PRESSURE MONITOR
-
批准号:2433891
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1997
-
负责人:WILLIAM GERIN
-
依托单位:
PATIENT FRIENDLY TELEPHONE LINKED BLOOD PRESSURE MONITOR
-
批准号:2702496
-
项目类别:
-
资助金额:$58.19万
-
财政年份:1997
-
负责人:WILLIAM GERIN
-
依托单位:
ACTIVE COPING AND SOCIAL SUPPORT EFFECT ON REACTIVITY
-
批准号:2224295
-
项目类别:
-
资助金额:$11.29万
-
财政年份:1993
-
负责人:WILLIAM GERIN
-
依托单位:
ACTIVE COPING AND SOCIAL SUPPORT EFFECT ON REACTIVITY
-
批准号:2224294
-
项目类别:
-
资助金额:$11.15万
-
财政年份:1993
-
负责人:WILLIAM GERIN
-
依托单位:
ACTIVE COPING AND SOCIAL SUPPORT EFFECT ON REACTIVITY
-
批准号:2224296
-
项目类别:
-
资助金额:$12.54万
-
财政年份:1993
-
负责人:WILLIAM GERIN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: